PLUR
PLUR
NASDAQ · Biotechnology

Pluri Inc

$2.02
+0.00 (+0.00%)
Financial Highlights (FY 2026)
Revenue
671.1K
Net Income
-38,450,706
Gross Margin
98.8%
Profit Margin
-6,407.4%
Rev Growth
+131.9%
D/E Ratio
250.28
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 98.8% 48.9% 30.3% 30.3%
Operating Margin -6,796.9% -1,493.9% -1.4% -1.5%
Profit Margin -6,407.4% -1,605.8% -1.8% -1.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 671.1K 1.18M 4.21M 5.36M
Gross Profit 662.9K 575.4K 1.28M 1.62M
Operating Income -45,614,808 -17,559,971 -59,264 -77,809
Net Income -38,450,706 -17,884,542 -76,163 -75,826
Gross Margin 98.8% 48.9% 30.3% 30.3%
Operating Margin -6,796.9% -1,493.9% -1.4% -1.5%
Profit Margin -6,407.4% -1,605.8% -1.8% -1.4%
Rev Growth +131.9% +78.7% +17.4% +13.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.85M 12.36M 10.60M 10.10M
Total Equity 43.4K 49.4K 12.82M 11.60M
D/E Ratio 250.28 250.29 0.83 0.87
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -37,219,619 -17,808,595 -73,642 -95,229
Free Cash Flow -41,548 -57,067